Foamix prices its follow-on offering of ordinary shares

Foamix Pharmaceuticals (NASDAQ:) its public offering of 11,670,000 ordinary shares at a price of $6.00 per share for expected gross proceeds of $70,020,000.

Underwriters over-allotment is an additional 1,750,500 ordinary shares.

Closing date is September 18.

Previously: (Sept. 12)

Now read:

for full text news in your inbox

Leave a Reply

Your email address will not be published. Required fields are marked *